Agendia To Play Pivotal Role In ISPY-2 Trial For Breast Cancer

[News]

Agendia, a world leader in molecular cancer diagnostics, announced it will participate in the highly anticipated I-SPY 2 TRIAL for breast cancer, set to launch at the first of nearly twenty research sites...

More... (http://mnt.to/f/3z6t)